State insurance regulators scouring for strategies to tackle surging premiums may also need to develop frameworks to cope with expensive specialty drugs that raise fresh affordability threats, an analyst from a national healthcare policy nonprofit suggested Monday.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Walmart, Target face a new price problem as costs surge | 0 | 10 | 16-10-2026 |
| 2 | Ohio loses one-third of Obamacare enrollees: Data | -2 | 6 | 07-07-2026 |
| 3 | The billion-dollar problem keeping Ozempic, Wegovy, and Zepbound from patients | 0 | 13.02 | 24-07-2026 |
| 4 | Insurers Are Pocketing Copay Assistance Funds Meant to Curb Patient Drug Costs | -2 | 6 | 07-07-2026 |
| 5 | States seek to lower drug prices by targeting the companies that manage them for health plans | 0 | 5 | 27-06-2026 |
| 6 | Obamacare rolls shrank dramatically in many states over the past year: Data | 0 | 8.19 | 07-07-2026 |
| 7 | Obamacare rolls shrank dramatically in many states over the past year: Data | -1 | 6 | 07-07-2026 |
| 8 | Millions Are Leaving ACA Plans as Premiums Rise. Here's Why | -2 | 6 | 05-07-2026 |
| 9 | Opinion: The primary care crisis paradox | 0 | 5 | 10-07-2026 |
| 10 | A Closer Look at AMCP | 0 | 6.87 | 20-10-2026 |